- Published on
Emergency And Acute Medicine: Hypertensive Emergencies
Basics
Description Hypertensive crisis refers to severe blood pressure elevation, typically SBP >179 mm Hg or DBP >109 mm Hg. Hypertensive urgency is severe BP elevation without acute end-organ injury. Hypertensive emergency is severe BP elevation with acute target-organ damage. In hypertensive emergency, autoregulation fails: arterioles initially constrict to protect capillary beds, but extreme pressures overwhelm this response, causing endothelial injury, increased permeability, platelet and coagulation activation, and fibrin deposition. Sympathetic and renin–angiotensin activation further increase vasoconstriction and inflammation, worsening ischemia and perpetuating a vicious cycle. Commonly affected organs include brain (encephalopathy, ischemic stroke, intracerebral hemorrhage), retina (hemorrhage, papilledema), heart (ACS, acute heart failure, aortic dissection), kidneys (acute renal failure), and placenta (preeclampsia/eclampsia).
Etiology Causes include essential hypertension; renal vascular or parenchymal disease; coarctation of the aorta; CNS injury (head trauma, stroke/ICH, tumor, spinal cord injury); endocrine disorders (pheochromocytoma, Cushing syndrome, primary hyperaldosteronism, renin-secreting tumors); drugs and toxins (cocaine, PCP, amphetamines, erythropoietin, tacrolimus, cyclosporine, corticosteroids, oral contraceptives, MAOI interactions, lead); withdrawal of antihypertensives; autonomic hyperreactivity (Guillain–Barré, acute intermittent porphyria); postoperative pain or anesthetic complications; and pregnancy-related disease (preeclampsia/eclampsia).
Diagnosis
History Review prescribed and OTC medications, antihypertensive adherence or withdrawal, duration and control of baseline hypertension, prior end-organ disease, comorbidities (CAD, diabetes, obesity), and recreational drug use. Screen for end-organ injury, commonly dyspnea, chest pain, headache, confusion, and focal neurologic deficits.
Physical exam Measure BP in both arms using appropriate cuff size. Assess for neurologic deficits and mental status changes, perform funduscopic exam for hemorrhages or papilledema, evaluate cardiovascular status (JVP, crackles, S3, aortic regurg murmur), and check for pulse asymmetry.
Essential workup Obtain a 12-lead ECG for ischemia and LVH, and assess kidney function because acute renal failure may be clinically silent.
Diagnosis tests and interpretation
Laboratory CBC (anemia and thrombocytopenia may indicate thrombotic microangiopathy), BMP including BUN/creatinine and electrolytes (hypokalemia suggests mineralocorticoid excess), urinalysis (protein, blood, casts), urine toxicology when drug use is suspected, and pregnancy test when appropriate. Use standard chest pain protocols when indicated.
Imaging Chest radiograph for cardiopulmonary symptoms, head CT for headache, confusion, or focal deficits, and CTA chest/abdomen if aortic dissection is suspected.
Procedures Consider arterial line monitoring in unstable cases. Lumbar puncture may be used to evaluate for subarachnoid hemorrhage after appropriate imaging.
Differential diagnosis ACS, acute heart failure, aortic dissection, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, preeclampsia/eclampsia, withdrawal syndromes (beta-blocker, clonidine), and catecholamine excess states (pheochromocytoma, sympathomimetic intoxication, tyramine reaction with MAOIs).
Treatment
Prehospital Support ABCs and consider cautious BP reduction only when clearly indicated.
Initial stabilization/therapy Provide oxygen as needed, establish IV access, monitor ECG and pulse oximetry.
Emergency department management Hypertensive urgency does not require IV reduction; give missed home medications, use oral agents only, and lower BP gradually over 24–48 hours with close follow-up. Hypertensive emergency requires IV therapy guided by the end-organ injury rather than the absolute BP. Reduce MAP by no more than 20–25% in the first hour, then target roughly SBP ~160 and DBP ~100 over 2–6 hours, transitioning to oral agents within 6–12 hours once stable. Lower more gradually in acute CNS injury, but more rapidly in aortic dissection. Hypertensive encephalopathy: lower MAP up to 20% or DBP to 100–110 within the first hour, then normalize over 48–72 hours using nicardipine, clevidipine, or labetalol. Ischemic stroke: treat only if SBP >220 or DBP >120, or if thrombolysis planned (target <185/110 pre-tPA, then <180/105); avoid reducing MAP more than 15–20% in the first 24 hours; preferred agents are nicardipine, clevidipine, or labetalol. ICH/SAH: treat if SBP >180 or DBP >100; aim SBP 140–160 or MAP down 20–25% in the first hour; avoid nitroglycerin and nitroprusside due to cerebral vasodilation and ICP effects; use nicardipine, clevidipine, or labetalol. ACS: target MAP 60–100 using labetalol or esmolol with nitroglycerin; avoid hydralazine and nitroprusside. Acute heart failure: target MAP 60–100 with nitroprusside or nitroglycerin plus ACE inhibitor and/or loop diuretic. Acute renal failure or microangiopathy: reduce MAP 20–25% in the first hour using nicardipine, clevidipine, or fenoldopam; ACE inhibitors are preferred for scleroderma renal crisis. Aortic dissection: reduce shear force by lowering HR and BP; beta-blockade must come first; target SBP 100–120 and HR <65 within 20 minutes using esmolol plus a vasodilator (dihydropyridine CCB or nitroprusside); obtain urgent surgical consultation for type A.
Sympathomimetic crisis: avoid pure beta-blockade; use phentolamine or calcium channel blocker plus benzodiazepines; use clonidine for clonidine withdrawal.
Pregnancy considerations Preeclampsia is SBP >140 or DBP >90 with proteinuria after 20 weeks to 4 weeks postpartum, often with headache, visual changes, edema, or RUQ pain; target SBP 130–150 and DBP 80–100 using labetalol, nicardipine, hydralazine, and magnesium, with obstetric consultation.
Medication Clevidipine 1–16 mg/h infusion; nicardipine 2–15 mg/h infusion; labetalol 20–80 mg IV q10 min (max 300 mg) or 0.5–2 mg/min infusion; esmolol 80 mg IV bolus then 150 μg/kg/min infusion; nitroglycerin 5–100 μg/min infusion; nitroprusside 0.25–10 μg/kg/min infusion; hydralazine 10–20 mg IV bolus; fenoldopam 0.1–0.6 μg/kg/min infusion; enalaprilat 1.25–5 mg IV q6h; phentolamine 5–15 mg IV q5–15 min.
Follow-up and disposition
Admission criteria Any patient with acute end-organ injury requires admission; ICU monitoring is indicated for hypertensive emergency.
Discharge criteria No end-organ injury, reliable follow-up, known hypertension, reversible trigger such as medication nonadherence, and ability to resume a safe outpatient regimen; provide strict return precautions for chest pain, neurologic symptoms, or severe headache.
Follow-up recommendations Ensure timely primary care follow-up for medication initiation or adjustment and long-term BP control.
Key points Do not use IV agents for hypertensive urgency. In hypertensive emergency, the initial goal is controlled MAP reduction of 20–25% in the first hour, except for ischemic stroke and aortic dissection where targets differ. Avoid precipitous BP drops that can worsen ischemia. In aortic dissection prevent reflex tachycardia by starting beta-blockade first. In catecholamine excess avoid unopposed alpha stimulation by avoiding pure beta-blockers.
Basics
Description Hypertensive crisis refers to severe blood pressure elevation, typically SBP >179 mm Hg or DBP >109 mm Hg. Hypertensive urgency is severe BP elevation without acute end-organ injury. Hypertensive emergency is severe BP elevation with acute target-organ damage. In hypertensive emergency, autoregulation fails: arterioles initially constrict to protect capillary beds, but extreme pressures overwhelm this response, causing endothelial injury, increased permeability, platelet and coagulation activation, and fibrin deposition. Sympathetic and renin–angiotensin activation further increase vasoconstriction and inflammation, worsening ischemia and perpetuating a vicious cycle. Commonly affected organs include brain (encephalopathy, ischemic stroke, intracerebral hemorrhage), retina (hemorrhage, papilledema), heart (ACS, acute heart failure, aortic dissection), kidneys (acute renal failure), and placenta (preeclampsia/eclampsia).
Etiology Causes include essential hypertension; renal vascular or parenchymal disease; coarctation of the aorta; CNS injury (head trauma, stroke/ICH, tumor, spinal cord injury); endocrine disorders (pheochromocytoma, Cushing syndrome, primary hyperaldosteronism, renin-secreting tumors); drugs and toxins (cocaine, PCP, amphetamines, erythropoietin, tacrolimus, cyclosporine, corticosteroids, oral contraceptives, MAOI interactions, lead); withdrawal of antihypertensives; autonomic hyperreactivity (Guillain–Barré, acute intermittent porphyria); postoperative pain or anesthetic complications; and pregnancy-related disease (preeclampsia/eclampsia).
Diagnosis
History Review prescribed and OTC medications, antihypertensive adherence or withdrawal, duration and control of baseline hypertension, prior end-organ disease, comorbidities (CAD, diabetes, obesity), and recreational drug use. Screen for end-organ injury, commonly dyspnea, chest pain, headache, confusion, and focal neurologic deficits.
Physical exam Measure BP in both arms using appropriate cuff size. Assess for neurologic deficits and mental status changes, perform funduscopic exam for hemorrhages or papilledema, evaluate cardiovascular status (JVP, crackles, S3, aortic regurg murmur), and check for pulse asymmetry.
Essential workup Obtain a 12-lead ECG for ischemia and LVH, and assess kidney function because acute renal failure may be clinically silent.
Diagnosis tests and interpretation
Laboratory CBC (anemia and thrombocytopenia may indicate thrombotic microangiopathy), BMP including BUN/creatinine and electrolytes (hypokalemia suggests mineralocorticoid excess), urinalysis (protein, blood, casts), urine toxicology when drug use is suspected, and pregnancy test when appropriate. Use standard chest pain protocols when indicated.
Imaging Chest radiograph for cardiopulmonary symptoms, head CT for headache, confusion, or focal deficits, and CTA chest/abdomen if aortic dissection is suspected.
Procedures Consider arterial line monitoring in unstable cases. Lumbar puncture may be used to evaluate for subarachnoid hemorrhage after appropriate imaging.
Differential diagnosis ACS, acute heart failure, aortic dissection, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, preeclampsia/eclampsia, withdrawal syndromes (beta-blocker, clonidine), and catecholamine excess states (pheochromocytoma, sympathomimetic intoxication, tyramine reaction with MAOIs).
Treatment
Prehospital Support ABCs and consider cautious BP reduction only when clearly indicated.
Initial stabilization/therapy Provide oxygen as needed, establish IV access, monitor ECG and pulse oximetry.
Emergency department management Hypertensive urgency does not require IV reduction; give missed home medications, use oral agents only, and lower BP gradually over 24–48 hours with close follow-up. Hypertensive emergency requires IV therapy guided by the end-organ injury rather than the absolute BP. Reduce MAP by no more than 20–25% in the first hour, then target roughly SBP ~160 and DBP ~100 over 2–6 hours, transitioning to oral agents within 6–12 hours once stable. Lower more gradually in acute CNS injury, but more rapidly in aortic dissection. Hypertensive encephalopathy: lower MAP up to 20% or DBP to 100–110 within the first hour, then normalize over 48–72 hours using nicardipine, clevidipine, or labetalol. Ischemic stroke: treat only if SBP >220 or DBP >120, or if thrombolysis planned (target <185/110 pre-tPA, then <180/105); avoid reducing MAP more than 15–20% in the first 24 hours; preferred agents are nicardipine, clevidipine, or labetalol. ICH/SAH: treat if SBP >180 or DBP >100; aim SBP 140–160 or MAP down 20–25% in the first hour; avoid nitroglycerin and nitroprusside due to cerebral vasodilation and ICP effects; use nicardipine, clevidipine, or labetalol. ACS: target MAP 60–100 using labetalol or esmolol with nitroglycerin; avoid hydralazine and nitroprusside. Acute heart failure: target MAP 60–100 with nitroprusside or nitroglycerin plus ACE inhibitor and/or loop diuretic. Acute renal failure or microangiopathy: reduce MAP 20–25% in the first hour using nicardipine, clevidipine, or fenoldopam; ACE inhibitors are preferred for scleroderma renal crisis. Aortic dissection: reduce shear force by lowering HR and BP; beta-blockade must come first; target SBP 100–120 and HR <65 within 20 minutes using esmolol plus a vasodilator (dihydropyridine CCB or nitroprusside); obtain urgent surgical consultation for type A.
Sympathomimetic crisis: avoid pure beta-blockade; use phentolamine or calcium channel blocker plus benzodiazepines; use clonidine for clonidine withdrawal.
Pregnancy considerations Preeclampsia is SBP >140 or DBP >90 with proteinuria after 20 weeks to 4 weeks postpartum, often with headache, visual changes, edema, or RUQ pain; target SBP 130–150 and DBP 80–100 using labetalol, nicardipine, hydralazine, and magnesium, with obstetric consultation.
Medication Clevidipine 1–16 mg/h infusion; nicardipine 2–15 mg/h infusion; labetalol 20–80 mg IV q10 min (max 300 mg) or 0.5–2 mg/min infusion; esmolol 80 mg IV bolus then 150 μg/kg/min infusion; nitroglycerin 5–100 μg/min infusion; nitroprusside 0.25–10 μg/kg/min infusion; hydralazine 10–20 mg IV bolus; fenoldopam 0.1–0.6 μg/kg/min infusion; enalaprilat 1.25–5 mg IV q6h; phentolamine 5–15 mg IV q5–15 min.
Follow-up and disposition
Admission criteria Any patient with acute end-organ injury requires admission; ICU monitoring is indicated for hypertensive emergency.
Discharge criteria No end-organ injury, reliable follow-up, known hypertension, reversible trigger such as medication nonadherence, and ability to resume a safe outpatient regimen; provide strict return precautions for chest pain, neurologic symptoms, or severe headache.
Follow-up recommendations Ensure timely primary care follow-up for medication initiation or adjustment and long-term BP control.
Key points Do not use IV agents for hypertensive urgency. In hypertensive emergency, the initial goal is controlled MAP reduction of 20–25% in the first hour, except for ischemic stroke and aortic dissection where targets differ. Avoid precipitous BP drops that can worsen ischemia. In aortic dissection prevent reflex tachycardia by starting beta-blockade first. In catecholamine excess avoid unopposed alpha stimulation by avoiding pure beta-blockers.
0 Comments
